Shu Chuen Li

1.7k total citations
61 papers, 1.2k citations indexed

About

Shu Chuen Li is a scholar working on Economics and Econometrics, Epidemiology and Geriatrics and Gerontology. According to data from OpenAlex, Shu Chuen Li has authored 61 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Economics and Econometrics, 14 papers in Epidemiology and 11 papers in Geriatrics and Gerontology. Recurrent topics in Shu Chuen Li's work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Shu Chuen Li is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (16 papers), Pharmaceutical Practices and Patient Outcomes (11 papers) and Parkinson's Disease Mechanisms and Treatments (7 papers). Shu Chuen Li collaborates with scholars based in Australia, Singapore and Vietnam. Shu Chuen Li's co-authors include Hwee Lin Wee, Nan Luo, Surachat Ngorsuraches, David Newby, Julian Thumboo, Louis Tan, Louis C.S. Tan, Wing‐Lok Au, Wing Lok Au and Nan Luo and has published in prestigious journals such as PLoS ONE, Movement Disorders and Vaccine.

In The Last Decade

Shu Chuen Li

60 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shu Chuen Li Australia 22 302 243 202 179 127 61 1.2k
Ken Lee Chin Australia 18 174 0.6× 419 1.7× 188 0.9× 246 1.4× 92 0.7× 40 1.6k
Michael R. Kolber Canada 21 139 0.5× 158 0.7× 207 1.0× 133 0.7× 109 0.9× 92 1.6k
Jane Masoli United Kingdom 16 315 1.0× 158 0.7× 124 0.6× 110 0.6× 39 0.3× 37 1.2k
Siti Setiati Indonesia 22 105 0.3× 257 1.1× 126 0.6× 111 0.6× 231 1.8× 138 1.7k
Chia Siang Kow Malaysia 20 321 1.1× 109 0.4× 115 0.6× 85 0.5× 43 0.3× 104 1.4k
Dong Wook Kim South Korea 23 102 0.3× 110 0.5× 219 1.1× 97 0.5× 50 0.4× 92 1.5k
Lise M. Bjerre Canada 19 88 0.3× 295 1.2× 123 0.6× 314 1.8× 110 0.9× 54 1.4k
Noam Y. Kirson United States 25 119 0.4× 127 0.5× 353 1.7× 236 1.3× 112 0.9× 87 1.8k
Celine Sze Ling Chui Hong Kong 28 259 0.9× 64 0.3× 245 1.2× 130 0.7× 110 0.9× 117 2.1k
Tariq M. Alhawassi Saudi Arabia 20 72 0.2× 497 2.0× 235 1.2× 204 1.1× 128 1.0× 61 1.7k

Countries citing papers authored by Shu Chuen Li

Since Specialization
Citations

This map shows the geographic impact of Shu Chuen Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Chuen Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Chuen Li more than expected).

Fields of papers citing papers by Shu Chuen Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shu Chuen Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Chuen Li. The network helps show where Shu Chuen Li may publish in the future.

Co-authorship network of co-authors of Shu Chuen Li

This figure shows the co-authorship network connecting the top 25 collaborators of Shu Chuen Li. A scholar is included among the top collaborators of Shu Chuen Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Chuen Li. Shu Chuen Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hua, Susan, et al.. (2023). Economic burden of advanced lung cancer patients treated by gefitinib alone and combined with chemotherapy in two regions of China. Journal of Medical Economics. 26(1). 1424–1431. 3 indexed citations
2.
3.
Nguyen, Duy H. N., et al.. (2022). Implementing clinical pharmacy activities in hospital setting in Vietnam: current status from a national survey. BMC Health Services Research. 22(1). 878–878. 7 indexed citations
4.
Hương, Nguyễn Thị Liên, et al.. (2019). Impact of pharmaceutical care in the improvement of medication adherence and quality of life for COPD patients in Vietnam. Respiratory Medicine. 153. 31–37. 23 indexed citations
5.
Hương, Nguyễn Thị Liên, et al.. (2018). Effectiveness of a short training program for community pharmacists to improve knowledge and practice of asthma counselling – A simulated patient study. Respiratory Medicine. 144. 50–60. 15 indexed citations
6.
Hương, Nguyễn Thị Liên, et al.. (2018). Pharmacists' training to improve inhaler technique of patients with COPD in Vietnam. International Journal of COPD. Volume 13. 1863–1872. 27 indexed citations
7.
Hure, Alexis, Roseanne Peel, Stephen Hancock, et al.. (2018). Pneumococcal polysaccharide vaccine associated with reduced lengths of stay for cardiovascular events hospital admissions. Vaccine. 36(49). 7520–7524. 2 indexed citations
8.
9.
10.
Zhang, Fang, Yu Yang, & Shu Chuen Li. (2016). Analysis of the Utilization Status of Essential Medicines in Beijing’s Community Health Institutions. Therapeutic Innovation & Regulatory Science. 51(1). 39–44. 7 indexed citations
11.
Kuo, Ho‐Chang, et al.. (2015). Association of Attention deficit hyperactivity disorder and Kawasaki disease: a nationwide population-based cohort study. Epidemiology and Psychiatric Sciences. 25(6). 573–580. 11 indexed citations
12.
13.
14.
Newby, David, et al.. (2015). Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis. Open Heart. 2(1). e000247–e000247. 54 indexed citations
15.
16.
Yap, Chun Wei, et al.. (2007). A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. International Journal of Medical Informatics. 77(6). 421–430. 33 indexed citations
17.
Wee, Hwee Lin, et al.. (2006). Meaning of Health-related Quality of Life among Children and Adolescents in an Asian Country: A Focus Group Approach. Quality of Life Research. 15(5). 821–831. 30 indexed citations
18.
19.
Li, Shu Chuen, et al.. (2005). Advice-giving on self-medication: perspectives of community pharmacists and consumers in Singapore. Journal of Clinical Pharmacy and Therapeutics. 30(3). 225–231. 27 indexed citations
20.
Lin, Raymond Tzer Pin, et al.. (2004). A retrospective drug utilization evaluation of vancomycin usage in paediatric patients. Journal of Clinical Pharmacy and Therapeutics. 29(4). 359–365. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ken Lee Chin Breakdown of academic impact, for papers by Michael R. Kolber Breakdown of academic impact, for papers by Jane Masoli Breakdown of academic impact, for papers by Siti Setiati Breakdown of academic impact, for papers by Chia Siang Kow Breakdown of academic impact, for papers by Dong Wook Kim Breakdown of academic impact, for papers by Lise M. Bjerre Breakdown of academic impact, for papers by Noam Y. Kirson Breakdown of academic impact, for papers by Celine Sze Ling Chui Breakdown of academic impact, for papers by Tariq M. Alhawassi
Rankless by CCL
2026